Articles for Clinical
February 24, 2017 |
This week, the top managed care stories included Republicans releasing an outline for replacing the Affordable Care Act, pharmacy benefit managers and pharmaceutical companies pointing fingers over drug costs, and findings on engagement for patients with chronic conditions.
February 24, 2017 | Surabhi Dangi-Garimella, PhD
Using body composition metrics to guide the dose in patients receiving anthracyclines-taxane–based chemotherapy for breast cancer can reduce treatment-related toxicity.
February 24, 2017 | AJMC Staff
February 23, 2017 | AJMC Staff
February 22, 2017 | Christina Mattina
At the 5th annual Patient-Centered Oncology Care® meeting, stakeholders shared their views on how bundled payments, clinical pathways, and other value-based approaches can be implemented in cancer care while ensuring adequate care quality.
February 21, 2017 | AJMC Staff
Population-level judgements on the value of therapies to treat multiple sclerosis don’t adequately depict the differences between how providers and payers view value compared with patients and how patients view value different from one another.
February 21, 2017 | Surabhi Dangi-Garimella, PhD
Including anti-cholesterol agents during adjuvant endocrine treatment can prevent breast cancer recurrence in hormone receptor–positive early-stage breast cancer.
February 20, 2017 | Mary Caffrey
Pam Mangat, MS, associate director for the TAPUR study in the research and analysis division of the American Society of Clinical Oncology, offered an update on the study at the 5th annual Patient-Centered Oncology Care® meeting.